Private Capital Advisors Inc. Lowers Stock Position in Danaher Co. (NYSE:DHR)

Private Capital Advisors Inc. reduced its stake in shares of Danaher Co. (NYSE:DHR) by 1.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 58,024 shares of the conglomerate’s stock after selling 1,141 shares during the period. Danaher makes up about 1.6% of Private Capital Advisors Inc.’s holdings, making the stock its 20th largest position. Private Capital Advisors Inc.’s holdings in Danaher were worth $13,319,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. FMR LLC lifted its holdings in Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock valued at $996,141,000 after buying an additional 535,254 shares during the period. International Assets Investment Management LLC boosted its position in Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after acquiring an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. boosted its position in Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after acquiring an additional 397,671 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its stake in Danaher by 82.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate’s stock worth $181,651,000 after acquiring an additional 295,187 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on DHR shares. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Stephens restated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Price Performance

DHR opened at $245.73 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a 1-year low of $225.42 and a 1-year high of $281.70. The company has a 50-day moving average of $234.90 and a 200-day moving average of $253.47. The company has a market capitalization of $177.49 billion, a P/E ratio of 46.90, a PEG ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 EPS. The business’s revenue was up 3.1% on a year-over-year basis. Equities analysts expect that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.